Advertisement
Clearmind Medicine Inc. (CMND)
NASDAQ: CMND
· Real-Time Price · USD
1.03
0.00 (0.00%)
At close: Apr 29, 2025, 3:34 PM
Company Description
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.
It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors.
The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021.
Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Clearmind Medicine Inc.
| Country | CA |
| IPO Date | Nov 15, 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Dr. Adi Zuloff-Shani Ph.D. |
Advertisement
Contact Details
Address: 1220 West 6th Avenue Vancouver, BC CA | |
| Website | https://www.clearmindmedicine.com |
Stock Details
| Ticker Symbol | CMND |
| Exchange | NASDAQ |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| CIK Code | 0001892500 |
| CUSIP Number | n/a |
| ISIN Number | CA1850534027 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Adi Zuloff-Shani Ph.D. | Chief Executive Officer |
| Adi Varon | Controller |
| Mylene Touboul | Accounting Manager |
| Prof. Mark Haden M.S.W. | Vice President of Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2025 | 6-K | Filing |
| Apr 23, 2025 | 6-K | Filing |
| Apr 17, 2025 | 6-K | Filing |
| Apr 10, 2025 | 6-K | Filing |
| Apr 08, 2025 | 6-K | Filing |
| Apr 01, 2025 | 6-K | Filing |
| Mar 24, 2025 | 6-K | Filing |
| Mar 19, 2025 | 6-K | Filing |
| Mar 18, 2025 | 6-K | Filing |
| Mar 13, 2025 | POS AM | Filing |